Evidence map›Paper›PMID 41069913›Full record

ArticleCureus2025

Pathological Outcomes Following Radical Prostatectomy for Low-Risk Prostate Cancer.

Kayna Fichadia, Aryan Kapur, Cheryl Fung, Basil Razi, Henry H Woo

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kayna FichadiaBlacktown Mount Druitt Clinical School, Western Sydney University, Blacktown, AUS.
Aryan KapurBlacktown Mount Druitt Clinical School, Western Sydney University, Blacktown, AUS.
Cheryl FungDepartment of Urology, Blacktown Hospital, Blacktown, AUS.
Basil RaziDepartment of Urology, Blacktown Hospital, Blacktown, AUS.
Henry H WooDepartment of Urology, Blacktown Hospital, Blacktown, AUS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction There is an increasing view that the standard of care for men diagnosed with low-risk prostate cancer (LRPC) should be conservative, whether it be with active surveillance (AS) or watchful waiting. The introduction of imaging such as prostate magnetic resonance imaging (MRI) and prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has provided additional tools to predict the likelihood of occult clinically significant prostate cancer (PC) prior to biopsy and may also play a role in predicting missed clinically significant prostate cancer when prostate biopsies are either negative or only find low-grade PC. The New South Wales Prostate Cancer Outcomes Registry (NSW-PCOR) lists radical prostatectomy (RP) for LRPC as a performance metric for participant urologists, to whom such data is provided through Quality Reports. Given that factors beyond a diagnosis of LRPC may influence a decision for RP, a high level of pathological upgrade is anticipated in men with LRPC undergoing surgery in contemporary practice. The aim of this study was to evaluate the final pathological outcomes of men with LRPC who had undergone an RP and what factors played a role in the decision to undergo surgery. Methods The NSW-PCOR Quality Reports were analyzed from inception, and 10 patients who had undergone RP for LRPC were identified. Data, including biopsy histopathology, RP histopathology, and indications for RP, were extracted from clinical records. Clinically significant PC was defined as a Gleason score of ≤3 + 4 or the presence of extraprostatic extension or seminal vesicle invasion. Results It was found that seven out of 10 men had clinically significant PC on their RP histopathology. For eight men, preoperative imaging with prostate MRI or PSMA PET/CT had suggested a mismatch between imaging and biopsy pathology of low-grade PC. Of these eight men, seven were found to have clinically significant PC on RP. Other reasons for RP being performed included young age at diagnosis and the request for intervention related to patient anxiety. Conclusion In this contemporary cohort of men undergoing RP for LRPC, clinically significant disease was correctly predicted for all but one, where imaging had prompted intervention. Caution needs to be applied both in instances of reliance on imaging to predict occult clinically significant PC, as well as in the appropriateness of assigning conservative management purely on the basis of PC risk stratification.

Indexed as

active surveillanceprostate cancerprostate mripsma pet/ctradical prostatectomy

Identifiers

PMID41069913
PMCPMC12507382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.